Assessment of Thyroid and Parathyroid Dysfunction in Hemodialysis Patients


  • Safaa Abdulhussein Majeed College of Medical and Healthy Techniques, Southern Technical University- Basrah, Iraq
  • Abdulkareem Mohammed Jewad College of Medical and Healthy Techniques, Southern Technical University- Basrah, Iraq.
  • Mohammed Younus Naji Al Atbee College of Medicine, Consultant Nephrologist, University of Basr


Hemodialysis, thyroid dysfunction, parathyroid dysfunction, electrolytes


Background; Thyroid and parathyroid dysfunction in hemodialysis patients is a critical medical
concern that arises due to the intricate relationship between kidney function and these endocrine
glands. Hemodialysis, a life-saving procedure for individuals with kidney failure, often disrupts
the delicate balance of hormones in the body. Thyroid dysfunction, characterized by alterations in
thyroid hormone levels, is common and can lead to fatigue, weight changes, and mood swings. On
the other hand, parathyroid dysfunction involves imbalances in calcium and phosphorus
metabolism, resulting in bone and cardiovascular complications. Monitoring and managing thyroid
and parathyroid health in hemodialysis patients is crucial to improving their overall well-being and
quality of life.
Case-control the study was conducted on 75 patients undergoing hemodialysis and 75 age-matched
healthy controls. Thyroid function tests and serum electrolytes were measured for each group.
Our results show a significant difference between patients and the control group in each oxidative
stress marker and serum electrolyte level.
From the results, we could conclude that thyroid and parathyroid dysfunction play a role in
hemodialysis and can affect the management of end-stage renal failure patients.


Abdel, H., Deraz, A., & Shawky, N. M. (2023). Assessment of Thyroid Disorders and Chronic

Kidney Disease : Review Article. 92(July), 5778–5783.

Akram, M., Munir, N., Daniyal, M., Egbuna, C., Găman, M.-A., Onyekere, P. F., & Olatunde, A.

(2020). Vitamins and Minerals: Types, Sources and their Functions. Functional Foods and

Nutraceuticals, August, 149–172.

Ataei, N., Bazargani, B., Ameli, S., Madani, A., Javadilarijani, F., Moghtaderi, M., Abbasi, A.,

Shams, S., & Ataei, F. (2014). Early detection of acute kidney injury by serum cystatin C in

critically ill children. Pediatric Nephrology, 29(1), 133–138.


Atif, M. (2016). The hemodialysis machine case study. Lecture Notes in Computer Science

(Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics),

, 329–343.

Badiu, C. (2018). The Thyroid and its Diseases - A Comprehensive Guide for the Clinician 1st

Edition. Acta Endocrinologica (Bucharest), 14(4), 574–574.

Balwan, W. K., & Kour, S. (2022). Thyroid Health & Methylation: What is the Link? Scholars

Journal of Applied Medical Sciences, 10(12), 2460–2468.

Bertinato, J. (2021). Iodine nutrition: Disorders, monitoring and policies. In Advances in Food and

Nutrition Research (1st ed., Vol. 96). Elsevier Inc.

Bichari, W., Khedr, E., Sayed, H., Elwasly, D., & Ezzat, H. (2020). Prevalence of thyroid function

abnormalities in patients with chronic renal failure under regular hemodialysis. Egyptian Journal

of Hospital Medicine, 80(1), 594–598.

Bikbov, B., Purcell, C. A., Levey, A. S., Smith, M., Abdoli, A., Abebe, M., Adebayo, O. M.,

Afarideh, M., Agarwal, S. K., Agudelo-Botero, M., Ahmadian, E., Al-Aly, Z., Alipour, V.,

Almasi-Hashiani, A., Al-Raddadi, R. M., Alvis-Guzman, N., Amini, S., Andrei, T., Andrei, C. L.,

… Murray, C. J. L. (2020). Global, regional, and national burden of chronic kidney disease, 1990–

: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 395(10225),


Covella, B., Vinturache, A. E., Cabiddu, G., Attini, R., Gesualdo, L., Versino, E., & Piccoli, G. B.

(2019). A systematic review and meta-analysis indicates long-term risk of chronic and end-stage

kidney disease after preeclampsia. Kidney International, 96(3), 711–727.

Dhillon-Jhattu, S., McGill, R. L., Ennis, J. L., Worcester, E. M., Zisman, A. L., & Coe, F. L.

(2023). Vitamin D and Parathyroid Hormone Levels in CKD. American Journal of Kidney

Diseases, 81(1), 122–124.

Disease, K. (2023). Spectrum of Thyroid Dysfunction in Patients with Chronic Kidney Disease in

Benin City, Nigeria. 1–13.

Dwi Payana, I. M., Tuti Arianthi, N. N., & Sila Darmana, I. M. (2020). High ureum and creatinine

level in 18-year-old male: first diagnosed with chronic kidney disease. Intisari Sains Medis, 11(1),

Ephraim, E., & Jewell, D. E. (2021). High Protein Consumption with Controlled Phosphorus Level

Increases Plasma Concentrations of Uremic Toxins in Cats with Early Chronic Kidney Disease.


Fedak, D., Kuźniewski, M., Fugiel, A., Wieczorek-Surdacka, E., Przepiorkowska-Hoyer, B., Jasik,

P., Miarka, P., Dumnicka, P., Kapusta, M., Solnica, B., & Sułowicz, W. (2016). Serum uromodulin

concentrations correlate with glomerular filtration rate in patients with chronic kidney disease.

Polskie Archiwum Medycyny Wewnetrznej, 126(12), 995–1004.

Gosmanova, E. O., Chen, K., Rejnmark, L., Mu, F., Swallow, E., Briggs, A., Ayodele, O., Sherry,

N., & Ketteler, M. (2021). Risk of Chronic Kidney Disease and Estimated Glomerular Filtration

Rate Decline in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study.

Advances in Therapy, 38(4), 1876–1888.

Hasani, N. J., Alkhafaji, N. A. K., & Anied, A. (2022). Chronic Kidney Disease and associated

Oxidative Stress with low levels of some important vital indicators. Journal of Pharmaceutical

Negative Results, 13(7), 312–316.

Iglesias, P., & Díez, J. J. (2009). Thyroid dysfunction and kidney disease. European Journal of

Endocrinology, 160(4), 503–515.

Jacquillet, G., & Unwin, R. J. (2019). Physiological regulation of phosphate by vitamin D,

parathyroid hormone (PTH) and phosphate (Pi). Pflugers Archiv European Journal of Physiology,

(1), 83–98.

Jager, K. J., Kovesdy, C., Langham, R., Rosenberg, M., Jha, V., & Zoccali, C. (2019). A single

number for advocacy and communication-worldwide more than 850 million individuals have

kidney diseases. Nephrology Dialysis Transplantation, 34(11), 1803–1805.

Jameson, M. G., Holloway, L. C., Vial, P. J., Vinod, S. K., & Metcalfe, P. E. (2010). A review of

methods of analysis in contouring studies for radiation oncology. Journal of Medical Imaging and

Radiation Oncology, 54(5), 401–410.

Kachhawa, P., & Sinha, V. (2019). Assessment of thyroid dysfunction, dyslipidemia and oxidative

stress in hypertensive end stage chronic renal disease patients in a teaching hospital in Western

Uttar Pradesh. Asian Journal of Medical Sciences, 10(5), 13–18.

Kashif, M., Hussain, M. S., Anis, M., & Shah, P. K. (2023). Thyroid Dysfunction and Chronic

Kidney Disease: A Study Among the Northeastern Population of India. Cureus, 15(5), 1–7.

Khatiwada, S., Rajendra, K. C., Gautam, S., Lamsal, M., & Baral, N. (2015). Thyroid dysfunction

and dyslipidemia in chronic kidney disease patients. BMC Endocrine Disorders, 15(1), 1–7.

Khatri, P., Chaudhary, S., Piryani, R. M., Jaiswal, N. K., Alamkhan, M., Shahi, A., Dhakal, P. R.,

& Koirala, S. (2019). Thyroid Function Abnormalities in Patients with End-Stage Renal Disease

Undergoing Hemodialyis. 18(9), 61–64.


Kopple, J. D., Kalantar-Zadeh, K., & Mehrotra, R. (2005). Risks of chronic metabolic acidosis in

patients with chronic kidney disease. Kidney International, Supplement, 67(95), 21–27.

Kritmetapak, K., & Pongchaiyakul, C. (2019). Parathyroid Hormone Measurement in Chronic

Kidney Disease: From Basics to Clinical Implications. International Journal of Nephrology, 2019.

Laibi, H., Jewad, A. M., & Salih, M. (2023). Role of Routine Markers in the Diagnosis of Patients

with Chronic Kidney Disease. Journal of Biomedicine and Biochemistry, 2(1), 28–35.

Levey, A. S., Titan, S. M., Powe, N. R., Coresh, J., & Inker, L. A. (2020). Kidney disease, race,

and gfr estimation. Clinical Journal of the American Society of Nephrology, 15(8), 1203–1212.

Luyckx, V. A., & Brenner, B. M. (2020). Clinical consequences of developmental programming

of low nephron number. Anatomical Record, 303(10), 2613–2631.

Luyckx, V. A., Tonelli, M., & Stanifer, J. W. (2018). The global burden of kidney disease and the

sustainable development goals. Bulletin of the World Health Organization, 96(6), 414-422C.

Mehan, S., Guo, T., Gitau, M. W., & Flanagan, D. C. (2017). Comparative study of different

stochasticweather generators for long-term climate data simulation. Climate, 5(2), 1–40.

Mehsen, J. T., Madhi, Z. S., & Madhi, I. S. (2020). Spinal Stenosis : What Outcome Should be

Expected ? Review the Latest Evidence Using the Assessment of Multiple Systematic Reviews

Appraisal Tool ( AMSTAR ). 117–121.

Mohamed, A., Eldin, B., Shafik, D. E., Sabry, I. M., Abdl, M., Rouf, E., Mahmoud, H., &

Mahmoud, A. (2023). Evaluation of Thyroid Functions in Patients with End Stage Renal Disease

in A Sample of Egyptian Populations. 90(January), 1382–1386.

Mohamedali, M., Reddy Maddika, S., Vyas, A., Iyer, V., & Cheriyath, P. (2014). Thyroid disorders

and chronic kidney disease. International Journal of Nephrology, 2014, 1–7.

N, R. S., & Gb, K. (2023). Journal of Medical - Clinical Research & Reviews Lipid Profile in

Chronic Renal Failure Patients on Haemodialysis. 7(6), 6–9.

Onose, G., Munteanu, C., Popescu, C., Rotariu, M., Turnea, M., Dogaru, G., Iliescu, G., Minea,

M., Ionescu, E. V., Oprea, C., Stanciu, L. E., & Sînziana, C. (2023). Exploring the Potential

Benefits of Natural Calcium-Rich Mineral Waters for Health and Wellness : A Systematic Review.


Palmer, B. F., & Clegg, D. J. (2019). Physiology and Pathophysiology of Potassium Homeostasis :

Core Curriculum 2019. American Journal of Kidney Diseases, 74(5), 682–695.

Palsson, R., & Waikar, S. S. (2018). Renal Functional Reserve Revisited. Advances in Chronic

Kidney Disease, 25(3), e1–e8.

Pasala, S., & Carmody, J. B. (2017). How to use... serum creatinine, cystatin C and GFR. Archives

of Disease in Childhood: Education and Practice Edition, 102(1), 37–43.

Perry, K. W., & Salusky, I. B. (2011). Chronic Kidney Disease Mineral and Bone Disorder.

Pediatric Bone: Biology and Diseases, 795–820.


Pisoschi, A. M., Pop, A., Iordache, F., Stanca, L., Predoi, G., & Serban, A. I. (2021). Oxidative

stress mitigation by antioxidants - An overview on their chemistry and influences on health status.

European Journal of Medicinal Chemistry, 209, 112891.

Rana, S., Soni, B., Darney, D. P. E., & Jeyan, J. V. M. (2022). Experimental Investigation of

Effects of T3 Hormones on Human Body and their Analysis. International Journal of Science and

Research (IJSR), Https://Www. Ijsr. Net/Get_abstract. Php, June, 785–789.

Rashighi, M., & Harris, J. E. (2017). 乳鼠心肌提取 HHS Public Access. Physiology & Behavior,

(3), 139–148.

Rhee, C. M., Brent, G. A., Kovesdy, C. P., Soldin, O. P., Nguyen, D., Budoff, M. J., Brunelli, S.

M., & Kalantar-Zadeh, K. (2015). Thyroid functional disease: An under-recognized cardiovascular

risk factor in kidney disease patients. Nephrology Dialysis Transplantation, 30(5), 724–737.

Scherbaum, W. A. (2023). Epidemiologie und Verlauf des Diabetes mellitus in Deutschland

Herausgeber: W. A Scherbaum, W. Kiess Autoren: G. Giani, H. U. Janka, H. Hauner, E. Standl,

R. Schiel, A. Neu, W. Rathmann, J. Rosenbauer. Diabetes.

Shrivastava, S., & Khare, N. (2023). Biochemical Assessments of Thyroid Profile and Renal

Function Test in Chronic Kidney Disease. International Journal of Current Science Research and

Review, 06(03), 2051–2054.

Suki, W. N., & Moore, L. W. (2016). Fósforo en erc . 6–9.

Tippannavar, S. H., & Shekhanawar, M. (2022). A study of Thyroid dysfunction in patients with

chronic kidney disease undergoing maintenance haemodialysis among the patients of tertiary care

hospital. International Journal of Advanced Biochemistry Research, 6(1), 10–12.

Vanholder, R., Gryp, T., & Glorieux, G. (2018). Urea and chronic kidney disease: The comeback

of the century? (in uraemia research). Nephrology Dialysis Transplantation, 33(1), 4–12.

Vega, M. W., Swartz, S. J., Devaraj, S., & Poyyapakkam, S. (2020a). Elevated serum creatinine:

But is it renal failure? Pediatrics, 146(1).

Vega, M. W., Swartz, S. J., Devaraj, S., & Poyyapakkam, S. (2020b). Elevated serum creatinine:

But is it renal failure? Pediatrics, 146(1), 146–148.

Wan, J., Li, W., & Zhong, Y. (2019). Parathyroidectomy decreases serum intact parathyroid

hormone and calcium levels and prolongs overall survival in elderly hemodialysis patients with

severe secondary hyperparathyroidism. Journal of Clinical Laboratory Analysis, 33(3), 1–6.

Wein, M. N., & Kronenberg, H. M. (2018). Regulation of bone remodeling by parathyroid

hormone. Cold Spring Harbor Perspectives in Medicine, 8(8).

Yamada, S., & Nakano, T. (2023). Role of Chronic Kidney Disease ( CKD )– Mineral and Bone

Disorder ( MBD ) in the Pathogenesis of Cardiovascular Disease in CKD. 1–16